News and Publications
-
Transthyretin Amyloidosis (ATTRv): Advancing Early Diagnosis Through Genetic Testing
Transthyretin amyloidosis (ATTRv) is a progressive, life-threatening, and often underdiagnosed disease caused by the deposition of toxic transthyretin (TTR) amyloid fibrils in multiple tissues and… Read more
-
Press Release. ARCHIMEDlife achieves ISO 27001 Certification for Information Security Management
ARCHIMEDlife News September 3, 2025Vienna, Austria – [03.09.2025] — ARCHIMEDlife, international disease-focused Medical Laboratories* in Precision Medicine for Rare Disease and Specialty Diagnostics, is proud to announce that it has successfully… Read more
-
Update on screening cut-offs for Gaucher and Pompe diseases
April 28, 2025Effective 1 May 2025, the cut-off values for enzymatic testing for Gaucher and Pompe diseases have changed.The new Glucocerebrosidase (Gaucher) cut-off is changed to >1.2 µmol/L/h (old… Read more
-
Award for Outstanding Achievements on Rare Diseases
We are very happy to share that our CEO, Dr. David C. Kasper, has been selected as the winner of the Award for Outstanding Achievements in… Read more
-
WORLDSymposium 2025 Poster Presentations – Updates on important diagnostic services
The WORLDSymposium for Lysosomal Storage Disorders convened in San Diego, CA, USA earlier this month. This important meeting brings together industry, physicians, advocate groups, and… Read more
-
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder characterized by progressive neurodegeneration due to a deficiency in the enzyme arylsulfatase-A (ARSA). This deficiency leads to… Read more